Fortress Biotech, Inc. (FBIO)
2.80
-0.01
(-0.36%)
USD |
NASDAQ |
Aug 27, 16:00
2.80
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech EPS Diluted (TTM) : 2.657 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.657 |
| March 31, 2026 | 3.182 |
| December 31, 2025 | -0.1195 |
| September 30, 2025 | -0.2677 |
| June 30, 2025 | -1.142 |
| March 31, 2025 | -2.318 |
| December 31, 2024 | -2.879 |
| September 30, 2024 | -3.281 |
| June 30, 2024 | -16.63 |
| March 31, 2024 | -19.55 |
| December 31, 2023 | -21.97 |
| September 30, 2023 | -24.88 |
| June 30, 2023 | -14.89 |
| March 31, 2023 | -14.85 |
| December 31, 2022 | -14.12 |
| September 30, 2022 | -15.13 |
| June 30, 2022 | -14.85 |
| March 31, 2022 | -11.90 |
| December 31, 2021 | -10.79 |
| September 30, 2021 | -6.961 |
| June 30, 2021 | -6.194 |
| March 31, 2021 | -8.452 |
| December 31, 2020 | -9.738 |
| September 30, 2020 | -12.04 |
| June 30, 2020 | -12.34 |
| Date | Value |
|---|---|
| March 31, 2020 | -13.09 |
| December 31, 2019 | -9.836 |
| September 30, 2019 | -12.27 |
| June 30, 2019 | -16.37 |
| March 31, 2019 | -19.67 |
| September 30, 2018 | -23.06 |
| June 30, 2018 | -27.54 |
| March 31, 2018 | -26.51 |
| December 31, 2017 | -24.06 |
| September 30, 2017 | -26.34 |
| June 30, 2017 | -21.09 |
| March 31, 2017 | -19.29 |
| December 31, 2016 | -19.44 |
| September 30, 2016 | -18.60 |
| June 30, 2016 | -20.70 |
| March 31, 2016 | -18.45 |
| December 31, 2015 | -18.45 |
| September 30, 2015 | -15.45 |
| June 30, 2015 | -10.50 |
| March 31, 2015 | -10.05 |
| December 31, 2014 | -8.55 |
| September 30, 2014 | -11.10 |
| June 30, 2014 | -12.75 |
| March 31, 2014 | -16.50 |
| December 31, 2013 | -18.60 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | -1.176 |
| Ironwood Pharmaceuticals, Inc. | 0.7668 |
| Kura Oncology, Inc. | -3.362 |
| Spero Therapeutics, Inc. | 0.1091 |
| Cue Biopharma, Inc. | -27.00 |